Evidence map›Paper›PMID 28696542›Full record

ArticleClinical and experimental pharmacology & physiology2017

(Pro)renin receptor activation increases profibrotic markers and fibroblast-like phenotype through MAPK-dependent ROS formation in mouse renal collecting duct cells.

Alexis A Gonzalez, Leonardo Zamora, Cristian Reyes-Martinez, Nicolas Salinas-Parra, Nicole Roldan, Catherina A Cuevas, Stefanny Figueroa, Alex Gonzalez-Vergara, Minolfa C Prieto

Abstract read
In one paragraph

Article in Clinical and experimental pharmacology & physiology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.1field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Therapeutic Implications of Ferroptosis in Renal Fibrosis.Frontiers in molecular biosciences · 2022
    Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. (Pro)renin receptor in the kidney: function and significance.American journal of physiology. Regulatory, integrative and comparative physiology · 2021
    Review
  13. Sox6 as a new modulator of renin expression in the kidney.American journal of physiology. Renal physiology · 2020
    Article
  14. The (pro)renin receptor in health and disease.Nature reviews. Nephrology · 2019
    Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Alexis A GonzalezInstituto de Química, Pontificia Universidad Católica de Valparaíso, Valparaiso, Chile.ORCID http://orcid.org/0000-0003-0323-1448
Leonardo ZamoraInstituto de Química, Pontificia Universidad Católica de Valparaíso, Valparaiso, Chile.
Cristian Reyes-MartinezInstituto de Química, Pontificia Universidad Católica de Valparaíso, Valparaiso, Chile.
Nicolas Salinas-ParraInstituto de Química, Pontificia Universidad Católica de Valparaíso, Valparaiso, Chile.
Nicole RoldanInstituto de Química, Pontificia Universidad Católica de Valparaíso, Valparaiso, Chile.
Catherina A CuevasDepartment of Physiology, School of Medicine, Tulane University, New Orleans, LA, USA.
Stefanny FigueroaInstituto de Química, Pontificia Universidad Católica de Valparaíso, Valparaiso, Chile.
Alex Gonzalez-VergaraInstituto de Química, Pontificia Universidad Católica de Valparaíso, Valparaiso, Chile.
Minolfa C PrietoDepartment of Physiology, School of Medicine, Tulane University, New Orleans, LA, USA.
Pontificia Universidad Católica de Valparaíso · CLTulane University · US

Funding

TULANE COBRE: TRANSGENIC &GENE-TARGETED ANIMAL COREP20RR017659 · NCRR · TULANE UNIVERSITY OF LOUISIANA · PI CHEN, JING · 2002 to 2011
$22.1M
Tulane Building Interdisciplinary Research Careers in Women's Health (BIRCWH)K12HD043451 · NICHD · TULANE UNIVERSITY OF LOUISIANA · PI KROUSEL-WOOD, MARIE · 2002 to 2023
$9.9M
Renal Function Derangements in HypertensionR01HL026371 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI NAVAR, LUIS GABRIEL · 1985 to 2010
$3.4M
PLEIOTROPIC EFFECTS OF PRORENIN RECEPOR IN COLLECTING DUCT AND INTRARENAL RAS ACTIVATIONR01DK104375 · NIDDK · TULANE UNIVERSITY OF LOUISIANA · PI PRIETO, MINOLFA C · 2014 to 2018
$1.7M
NCRR NIH HHS P20 RR017659NHLBI NIH HHS R01 HL026371NICHD NIH HHS K12 HD043451NIDDK NIH HHS R01 DK104375
6 · The paper itself

Abstract

Recent studies suggested that activation of the PRR upregulates profibrotic markers through reactive oxygen species (ROS) formation; however, the exact mechanisms have not been investigated in CD cells. We hypothesized that activation of the PRR increases the expression of profibrotic markers through MAPK-dependent ROS formation in CD cells. Mouse renal CD cell line (M-1) was treated with recombinant prorenin plus ROS or MAPK inhibitors and PRR-shRNA to evaluate their effect on the expression of profibrotic markers. PRR immunostaining revealed plasma membrane and intracellular localization. Recombinant prorenin increases ROS formation (6.0 ± 0.5 vs 3.9 ± 0.1 nmol/L DCF/μg total protein, P < .05) and expression of profibrotic markers CTGF (149 ± 12%, P < .05), α-SMA (160 ± 20%, P < .05), and PAI-I (153 ± 13%, P < .05) at 10

Indexed as

AnimalsBiomarkersCell LineFibroblastsFibrosisKidneyMiceMitogen-Activated Protein Kinase 1Mitogen-Activated Protein Kinase 3Mitogen-Activated Protein KinasesPhosphorylationProrenin ReceptorReactive Oxygen SpeciesReceptors, Cell SurfaceBiomarkersMitogen-Activated Protein Kinase 1Mitogen-Activated Protein Kinase 3Mitogen-Activated Protein KinasesProrenin ReceptorReactive Oxygen SpeciesReceptors, Cell Surfacecollecting duct renninfibrosisintrarenal renin-angiotensin systemprorenin receptorreactive oxygen species

Identifiers

PMID28696542
PMCPMC5643228
OpenAlexW2735637054

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.